Complementary and alternative medicine use in glioma patients in France
Purpose Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas. Methods Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0–2 during hospital visits...
Gespeichert in:
| Veröffentlicht in: | Journal of neuro-oncology 2019-12, Vol.145 (3), p.487-499 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 499 |
|---|---|
| container_issue | 3 |
| container_start_page | 487 |
| container_title | Journal of neuro-oncology |
| container_volume | 145 |
| creator | Le Rhun, Emilie Devos, Patrick Bourg, Véronique Darlix, Amélie Lorgis, Véronique Ahle, Guido Boone, Mathieu Taillandier, Luc Curtit, Elsa Gras, Louis Lebrun Frenay, Christine Gramatzki, Dorothee Ramirez, Carole Simon, Nicolas Weller, Michael |
| description | Purpose
Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
Methods
Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0–2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted.
Results
Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures.
Conclusions
CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers. |
| doi_str_mv | 10.1007/s11060-019-03315-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03033555v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2307739555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-f9ff28ce83c44a222cf2a9e20e2ef2b5df5c10aa65c1f18dab34b4c5883bf4403</originalsourceid><addsrcrecordid>eNp9kU9P3DAQxS0E6i60X6CHKhKXcggde-w4OaJVWZBW4kKl3izHO4as8mcbJyvx7XEIUIkDp5Fmfm9m9B5j3zlccgD9K3AOGaTAixQQuUrzI7bkSmOqUeMxWwLPdKoK-XfBTkPYAYDUyL-wBfIMdSbyJVuvumZfU0PtYPunxLbbxNYD9a0dqgMlDW0rV7WUjIGSqk0e6qprbLKP06gIU-u6t62jr-zE2zrQt9d6xv5c_75f3aSbu_Xt6mqTOqlwSH3hvcgd5eiktEII54UtSAAJ8qJUW68cB2uzWDzPt7ZEWUqn8hxLLyXgGbuY9z7a2uz7qolfm85W5uZqY6YeYPRCKXXgkf05s_u--zdSGExTBUd1bVvqxmAEgtZYRDii5x_QXTdGE-qJ4kU0GrOJEjPl-i6Envz7BxzMFImZIzExEvMSicmj6Mfr6rGMdr5L3jKIAM5AiKP2gfr_tz9Z-wxbxZVk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2319110365</pqid></control><display><type>article</type><title>Complementary and alternative medicine use in glioma patients in France</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Le Rhun, Emilie ; Devos, Patrick ; Bourg, Véronique ; Darlix, Amélie ; Lorgis, Véronique ; Ahle, Guido ; Boone, Mathieu ; Taillandier, Luc ; Curtit, Elsa ; Gras, Louis ; Lebrun Frenay, Christine ; Gramatzki, Dorothee ; Ramirez, Carole ; Simon, Nicolas ; Weller, Michael</creator><creatorcontrib>Le Rhun, Emilie ; Devos, Patrick ; Bourg, Véronique ; Darlix, Amélie ; Lorgis, Véronique ; Ahle, Guido ; Boone, Mathieu ; Taillandier, Luc ; Curtit, Elsa ; Gras, Louis ; Lebrun Frenay, Christine ; Gramatzki, Dorothee ; Ramirez, Carole ; Simon, Nicolas ; Weller, Michael</creatorcontrib><description>Purpose
Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
Methods
Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0–2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted.
Results
Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures.
Conclusions
CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-019-03315-8</identifier><identifier>PMID: 31637628</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acupuncture ; Adult ; Alternative medicine ; Automatic ; Brain Neoplasms - therapy ; Cancer ; Clinical Study ; Complementary Therapies - economics ; Complementary Therapies - methods ; Complementary Therapies - statistics & numerical data ; Dietary supplements ; Engineering Sciences ; Expenditures ; Female ; France ; Glioblastoma ; Glioma ; Glioma - therapy ; Humans ; Life Sciences ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Neurology ; Oncology ; Patients ; Quality of life ; Questionnaires ; Surveys and Questionnaires ; Vitamins</subject><ispartof>Journal of neuro-oncology, 2019-12, Vol.145 (3), p.487-499</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Journal of Neuro-Oncology is a copyright of Springer, (2019). All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-f9ff28ce83c44a222cf2a9e20e2ef2b5df5c10aa65c1f18dab34b4c5883bf4403</citedby><cites>FETCH-LOGICAL-c453t-f9ff28ce83c44a222cf2a9e20e2ef2b5df5c10aa65c1f18dab34b4c5883bf4403</cites><orcidid>0000-0002-9408-3278 ; 0000-0002-9422-793X ; 0000-0001-5257-440X ; 0009-0006-7248-7753 ; 0000-0002-1748-174X ; 0000-0003-1384-1709</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-019-03315-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-019-03315-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31637628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03033555$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Rhun, Emilie</creatorcontrib><creatorcontrib>Devos, Patrick</creatorcontrib><creatorcontrib>Bourg, Véronique</creatorcontrib><creatorcontrib>Darlix, Amélie</creatorcontrib><creatorcontrib>Lorgis, Véronique</creatorcontrib><creatorcontrib>Ahle, Guido</creatorcontrib><creatorcontrib>Boone, Mathieu</creatorcontrib><creatorcontrib>Taillandier, Luc</creatorcontrib><creatorcontrib>Curtit, Elsa</creatorcontrib><creatorcontrib>Gras, Louis</creatorcontrib><creatorcontrib>Lebrun Frenay, Christine</creatorcontrib><creatorcontrib>Gramatzki, Dorothee</creatorcontrib><creatorcontrib>Ramirez, Carole</creatorcontrib><creatorcontrib>Simon, Nicolas</creatorcontrib><creatorcontrib>Weller, Michael</creatorcontrib><title>Complementary and alternative medicine use in glioma patients in France</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>Purpose
Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
Methods
Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0–2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted.
Results
Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures.
Conclusions
CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.</description><subject>Acupuncture</subject><subject>Adult</subject><subject>Alternative medicine</subject><subject>Automatic</subject><subject>Brain Neoplasms - therapy</subject><subject>Cancer</subject><subject>Clinical Study</subject><subject>Complementary Therapies - economics</subject><subject>Complementary Therapies - methods</subject><subject>Complementary Therapies - statistics & numerical data</subject><subject>Dietary supplements</subject><subject>Engineering Sciences</subject><subject>Expenditures</subject><subject>Female</subject><subject>France</subject><subject>Glioblastoma</subject><subject>Glioma</subject><subject>Glioma - therapy</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Oncology</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Surveys and Questionnaires</subject><subject>Vitamins</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9P3DAQxS0E6i60X6CHKhKXcggde-w4OaJVWZBW4kKl3izHO4as8mcbJyvx7XEIUIkDp5Fmfm9m9B5j3zlccgD9K3AOGaTAixQQuUrzI7bkSmOqUeMxWwLPdKoK-XfBTkPYAYDUyL-wBfIMdSbyJVuvumZfU0PtYPunxLbbxNYD9a0dqgMlDW0rV7WUjIGSqk0e6qprbLKP06gIU-u6t62jr-zE2zrQt9d6xv5c_75f3aSbu_Xt6mqTOqlwSH3hvcgd5eiktEII54UtSAAJ8qJUW68cB2uzWDzPt7ZEWUqn8hxLLyXgGbuY9z7a2uz7qolfm85W5uZqY6YeYPRCKXXgkf05s_u--zdSGExTBUd1bVvqxmAEgtZYRDii5x_QXTdGE-qJ4kU0GrOJEjPl-i6Envz7BxzMFImZIzExEvMSicmj6Mfr6rGMdr5L3jKIAM5AiKP2gfr_tz9Z-wxbxZVk</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Le Rhun, Emilie</creator><creator>Devos, Patrick</creator><creator>Bourg, Véronique</creator><creator>Darlix, Amélie</creator><creator>Lorgis, Véronique</creator><creator>Ahle, Guido</creator><creator>Boone, Mathieu</creator><creator>Taillandier, Luc</creator><creator>Curtit, Elsa</creator><creator>Gras, Louis</creator><creator>Lebrun Frenay, Christine</creator><creator>Gramatzki, Dorothee</creator><creator>Ramirez, Carole</creator><creator>Simon, Nicolas</creator><creator>Weller, Michael</creator><general>Springer US</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-9408-3278</orcidid><orcidid>https://orcid.org/0000-0002-9422-793X</orcidid><orcidid>https://orcid.org/0000-0001-5257-440X</orcidid><orcidid>https://orcid.org/0009-0006-7248-7753</orcidid><orcidid>https://orcid.org/0000-0002-1748-174X</orcidid><orcidid>https://orcid.org/0000-0003-1384-1709</orcidid></search><sort><creationdate>20191201</creationdate><title>Complementary and alternative medicine use in glioma patients in France</title><author>Le Rhun, Emilie ; Devos, Patrick ; Bourg, Véronique ; Darlix, Amélie ; Lorgis, Véronique ; Ahle, Guido ; Boone, Mathieu ; Taillandier, Luc ; Curtit, Elsa ; Gras, Louis ; Lebrun Frenay, Christine ; Gramatzki, Dorothee ; Ramirez, Carole ; Simon, Nicolas ; Weller, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-f9ff28ce83c44a222cf2a9e20e2ef2b5df5c10aa65c1f18dab34b4c5883bf4403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acupuncture</topic><topic>Adult</topic><topic>Alternative medicine</topic><topic>Automatic</topic><topic>Brain Neoplasms - therapy</topic><topic>Cancer</topic><topic>Clinical Study</topic><topic>Complementary Therapies - economics</topic><topic>Complementary Therapies - methods</topic><topic>Complementary Therapies - statistics & numerical data</topic><topic>Dietary supplements</topic><topic>Engineering Sciences</topic><topic>Expenditures</topic><topic>Female</topic><topic>France</topic><topic>Glioblastoma</topic><topic>Glioma</topic><topic>Glioma - therapy</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Oncology</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Surveys and Questionnaires</topic><topic>Vitamins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Rhun, Emilie</creatorcontrib><creatorcontrib>Devos, Patrick</creatorcontrib><creatorcontrib>Bourg, Véronique</creatorcontrib><creatorcontrib>Darlix, Amélie</creatorcontrib><creatorcontrib>Lorgis, Véronique</creatorcontrib><creatorcontrib>Ahle, Guido</creatorcontrib><creatorcontrib>Boone, Mathieu</creatorcontrib><creatorcontrib>Taillandier, Luc</creatorcontrib><creatorcontrib>Curtit, Elsa</creatorcontrib><creatorcontrib>Gras, Louis</creatorcontrib><creatorcontrib>Lebrun Frenay, Christine</creatorcontrib><creatorcontrib>Gramatzki, Dorothee</creatorcontrib><creatorcontrib>Ramirez, Carole</creatorcontrib><creatorcontrib>Simon, Nicolas</creatorcontrib><creatorcontrib>Weller, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Rhun, Emilie</au><au>Devos, Patrick</au><au>Bourg, Véronique</au><au>Darlix, Amélie</au><au>Lorgis, Véronique</au><au>Ahle, Guido</au><au>Boone, Mathieu</au><au>Taillandier, Luc</au><au>Curtit, Elsa</au><au>Gras, Louis</au><au>Lebrun Frenay, Christine</au><au>Gramatzki, Dorothee</au><au>Ramirez, Carole</au><au>Simon, Nicolas</au><au>Weller, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complementary and alternative medicine use in glioma patients in France</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>145</volume><issue>3</issue><spage>487</spage><epage>499</epage><pages>487-499</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>Purpose
Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
Methods
Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0–2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted.
Results
Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures.
Conclusions
CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31637628</pmid><doi>10.1007/s11060-019-03315-8</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-9408-3278</orcidid><orcidid>https://orcid.org/0000-0002-9422-793X</orcidid><orcidid>https://orcid.org/0000-0001-5257-440X</orcidid><orcidid>https://orcid.org/0009-0006-7248-7753</orcidid><orcidid>https://orcid.org/0000-0002-1748-174X</orcidid><orcidid>https://orcid.org/0000-0003-1384-1709</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-594X |
| ispartof | Journal of neuro-oncology, 2019-12, Vol.145 (3), p.487-499 |
| issn | 0167-594X 1573-7373 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_03033555v1 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Acupuncture Adult Alternative medicine Automatic Brain Neoplasms - therapy Cancer Clinical Study Complementary Therapies - economics Complementary Therapies - methods Complementary Therapies - statistics & numerical data Dietary supplements Engineering Sciences Expenditures Female France Glioblastoma Glioma Glioma - therapy Humans Life Sciences Male Medicine Medicine & Public Health Middle Aged Neurology Oncology Patients Quality of life Questionnaires Surveys and Questionnaires Vitamins |
| title | Complementary and alternative medicine use in glioma patients in France |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T11%3A51%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complementary%20and%20alternative%20medicine%20use%20in%20glioma%20patients%20in%20France&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Le%20Rhun,%20Emilie&rft.date=2019-12-01&rft.volume=145&rft.issue=3&rft.spage=487&rft.epage=499&rft.pages=487-499&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-019-03315-8&rft_dat=%3Cproquest_hal_p%3E2307739555%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2319110365&rft_id=info:pmid/31637628&rfr_iscdi=true |